Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREEDOM: Progesterone Callavid in Luteal Phase Insufficiency
NCT07136922Phase 1Recruiting
- Sponsor
- Calla Lily Clinical Care
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Crinone in luteal phase deficiency (LPD) (2 arms), sponsored by Calla Lily Clinical Care. Primary endpoint: Adverse Events. Started Apr 2026; status: recruiting.
02
Drugs
Crinone
03
Conditions
luteal phase deficiency (LPD)
Beyond the preview
Go deeper on NCT07136922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07136922.